B3-046 - Fungal Drugs Flashcards
Membrane-active agents
Amphotericin B
Nystatin
Cell wall synthesis inhibitors
Caspofungin
Azole derivatives
Ketoconazole
Itraconazole
Fluconazole
Voriconazole
Antimetabolite
Flucytosine
Microtubule poison
Griseofulvin
Allyl amines
Terbinafine
Flucytosine mechanism
Activated by fungal cytosine deaminase
converted to 5-fluorouracil (5-FU) which blocks DNA and RNA synthesis by inhibiting thymidylate synthase
Flucytosine pharmacokinetics
Orally effective, well distributed, including CNS
Excreted in urine
Flucytosine adverse effects
Low tax to patients (not activated in mammalian cells)
Flucytosine clinical uses
Narrow spectrum - cryptococcus, some candida
Resistance develops rapidly, use only with amphotericin B or -azoles
Fungi use ____ instead of cholesterol
Ergosterol
Amphotericin B mechanism
Polyene macrolide anti fungal - binds to ergosterol in fungal membrane - makes plasma mem leaky and cell dies from pore formation and leakage
Amphotericin B Pharmacokinetics
Must give IV or direct to CNS
widely distributed (IV doesn’t cover CNS)
very slow excretion (t-1/2 = 2 weeks)
Amphotericin B should be administered _____ due to its slow excretion time
Low and slow (infusion, slow IV drip)
Liposomal Amphotericin B
Liposomal reservoir of amphotericin. Increases effectiveness, decreases toxicity
Affinities of amphotericin B for Fungal membranes, liposome, and human membrane
Fungal mem - 10
Liposome - 1
Human mem - 0.1
Amphotericin B clinical uses
Most important drug for mucous - cryptococcus meningitis, blastomyces, candida, coccidoides, more
Broad spectrum antifungal
Use for initial intervention, then switch to other anti-fungals for maintenance/cure
Amphotericin B adverse effects
“Ampho-terrible B”
Shake and Banke
- chills, fever, nausea, vomiting, headache
usually medicate to suppress adverse effects
Common irreversible nephrotox